FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,754,000 | -14.3% | 80,000 | +60.0% | 0.17% | -60.1% |
| Q3 2017 | $2,046,000 | +126.6% | 50,000 | +66.7% | 0.43% | +93.3% |
| Q2 2017 | $903,000 | -16.8% | 30,000 | 0.0% | 0.22% | -31.2% |
| Q1 2017 | $1,085,000 | -43.0% | 30,000 | -34.6% | 0.32% | +13.7% |
| Q4 2015 | $1,905,000 | +206.3% | 45,900 | +14.8% | 0.28% | -33.4% |
| Q2 2014 | $622,000 | -45.1% | 40,000 | -30.6% | 0.43% | -47.2% |
| Q1 2014 | $1,132,000 | +236.9% | 57,600 | +188.0% | 0.81% | +1346.4% |
| Q4 2013 | $336,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |